The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
for the herto positive the transformative event was the development of trastuzamab or her septin which uh the data came forward in 2005 for early stage breast cancer that adding trastuzamab dramatically improved uh the chances of never hearing from the cancer again and that became totally standard for herto driven uh breast cancers
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
for the herto positive the transformative event was the development of tres tmab or her septin which uh the data came forward in 2005 for early stage breast cancer that adding trastuzamab dramatically improved uh the chances of never hearing from the cancer again and that became totally standard for heru driven uh breast cancers